Synthesis of 2-Hydroxy-5-(1-(2-(pyrazine-2-carbonyl) hydrazono)hexyl) Benzoic Acid, A Pyrazinamide Analog of Salicylic Acid
AbstractThe occurrence of resistant strains of Mycobacterium tuberculosis has driven current research on combining current anti-tuberculosis drugs and other bioactive molecules to enhance their efficacy against susceptible and resistant strains of the bacteria. In this study, a salicylic acid derivative of pyrazinamide, 2-hydroxy-5-(1-(2-(pyrazine-2-carbonyl)hydrazono)hexyl) benzoic acid was synthesized and characterized. The compound was prepared by coupling a pyrazinamide moiety, one of the first line drugs used to treat tuberculosis and a salicylic acid derivative with a 6-carbon alkyl chain. The salicylic acid derivative was generated via Friedel-Crafts acylation of methyl salicylate followed by base hydrolysis of the acylated product. This was coupled with the pyrazinamide moiety via imine formation. The product, 2-hydroxy-5-(1-(2-(pyrazine-2-carbonyl)hydrazono)hexyl) benzoic acid was obtained as an off-white powder in 62% yield.
Byrne ST, Denkin SM, Zhang Y. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis. J Antimicrob Chemother. 2007; 59:313-316.
Division of Tuberculosis Elimination [Internet]. [Place unknown]: Center for Disease Control and Prevention; 2012 Jul 19. Available from: http://www.cdc.gov/tb/.
Chen ZF, Huang Q, Li YY, Zhang Y, Ren Y, Li KS, et al. Nutrient starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi. 2007 May; 30(5):359-362.
Heany, H. The Bimolecular Aromatic Friedel-Crafts Reaction. In: Flemming I and Trost B, editors. Comprehensive Organic Synthesis: Selectivity, Strategy and Efficiency in Modern Organic Chemistry. England: Pergamon Press; 1991. p. 733-752.
Imramovský A, Polanc S, Vinšováa J, Kočevarb M, Jampílekc J, Rečkovác Z, et al. A new modification of anti-tubercular active molecules. Bioorg Med Chem. 2007; 15:2551-2559.
Lagua FM. Synthesis and Characterization of Novel Pyrazinamide Analogues of Salicylic acid and Aspirin [thesis]. [Manila]: De La Salle University; 2011.
Mitchison DA, Zhang Y. Recent Developments on the Study of Pyrazinamide: An Update. In: Donald PR, van Helden PD, editors. Antituberculosis Chemotherapy. Basel: Karger; 2011. p. 32-43. (Bollinger CT, editor. Progress in Respiratory Research; vol. 40).
Sriram D, Yogeeswari P, Reddy SP. Synthesis of pyrazinamide Mannich bases and its antitubercular properties. Bioorg Med Chem Lett. 2006; 16:2113-2116.
Swamy B, Suma T, Rao G, Reddy C. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis. Eur J Med Chem. 2007; 42:420-424.
Todar K. Todar’s Online Textbook of Bacteriology: Tuberculosis (Mycobacterium tuberculosis) [Internet]. [Place unknown]: [Publisher unknown]; 2012. Available from: http://textbookofbacteriology.net/tuberculosis.html.
Vergara FMF, Lima CH, Henriques MM, Cande ALP, Lourenco MCS, Ferreira M, et al. Synthesis and antimycobacterial activity of N’-[(E)-(monosubstitutedbenzylidene)]-2-pyrazinecarbohydrazide derivatives. Eur J Med Chem. 2009; 44:4954-4959.
WHO Global TB Control Report 2011 [Internet]. [Place unknown]: World Health Organization; 2012 Mar. Available from: http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf.
World Health Organization (October 2012) WHO Global Tuberculosis Report 2012. Retrieved from the World Wide Web:http://www.who.int/tb/publications/global_report/gtbr12_executivesummary.pdf.
Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother. 2003; 52:790-795.
Zitko J, Jampilek J, Dobrovolny L, Svobodova M, Kunes J, Dolezal M. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles. Bioorg Med Chem. 2012; 22:1598-1601.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).